| Literature DB >> 31293536 |
Alessandra Fontana1, Irene Falasconi1, Paola Molinari1, Laura Treu2, Arianna Basile2, Alessandro Vezzi2, Stefano Campanaro2,3, Lorenzo Morelli1.
Abstract
Lactobacillus helveticus belongs to the large group of lactic acid bacteria (LAB), which are the major players in the fermentation of a wide range of foods. LAB are also present in the human gut, which has often been exploited as a reservoir of potential novel probiotic strains, but several parameters need to be assessed before establishing their safety and potential use for human consumption. In the present study, six L. helveticus strains isolated from natural whey cultures were analyzed for their phenotype and genotype in exopolysaccharide (EPS) production, low pH and bile salt tolerance, bile salt hydrolase (BSH) activity, and antibiotic resistance profile. In addition, a comparative genomic investigation was performed between the six newly sequenced strains and the 51 publicly available genomes of L. helveticus to define the pangenome structure. The results indicate that the newly sequenced strain UC1267 and the deposited strain DSM 20075 can be considered good candidates for gut-adapted strains due to their ability to survive in the presence of 0.2% glycocholic acid (GCA) and 1% taurocholic and taurodeoxycholic acid (TDCA). Moreover, these strains had the highest bile salt deconjugation activity among the tested L. helveticus strains. Considering the safety profile, none of these strains presented antibiotic resistance phenotypically and/or at the genome level. The pangenome analysis revealed genes specific to the new isolates, such as enzymes related to folate biosynthesis in strains UC1266 and UC1267 and an integrated phage in strain UC1035. Finally, the presence of maltose-degrading enzymes and multiple copies of 6-phospho-β-glucosidase genes in our strains indicates the capability to metabolize sugars other than lactose, which is related solely to dairy niches.Entities:
Keywords: Lactobacillus helveticus; antibiotic resistance; bile salts tolerance; comparative genomics; exopolysaccharides; lactic acid bacteria; probiotics
Year: 2019 PMID: 31293536 PMCID: PMC6606699 DOI: 10.3389/fmicb.2019.01380
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
FIGURE 1Representation of L. helveticus gene content reporting how the pan genome varies as genomes are added in random order to the analysis. In the y axes, the number of genes is reported, while in the x axes, the number of strains considered is shown. Both unique genes (azure) and new genes (red) are reported.
FIGURE 2Phylogenetic trees of the 57 L. helveticus strains. The six strains newly sequenced in the present work are highlighted with a yellow star. The color choice depicts the isolation source of each strain, and the corresponding country of isolation is reported on the two external columns. Tree based on SNPs identified by Parsnp among the strains (A). Tree based on orthologous genes found by Roary among the strains (B). The length of each branch is proportional to the number of SNPs and orthologs found, respectively.
FIGURE 3Gene content comparison of the 57 considered L. helveticus strains. (A) The number of genes belonging to the core, the soft core, the shell, or the cloud of the L. helveticus species is pictured as a pie chart. The six strains newly sequenced in the present work are highlighted with a yellow star. (B) The matrix shows genes typical of each strain and those conserved in all.
FIGURE 4Gene content in the considered categories for the 57 investigated L. helveticus strains according to Roary.
FIGURE 5Comparison between the newly sequenced strains and publicly available strains genome mining for epithelial adherence and aggregation features.
FIGURE 6Percentage of growth of the L. helveticus strains isolated in this study in the presence of bile salts (A) GCA: glycocholic acid. (B) GDCA: glycodeoxycholic acid. (C) TCA: taurocholic acid. (D) TDCA: taurodeoxycholic acid.
FIGURE 7Bile salt hydrolase activity in the L. helveticus strains isolated and newly sequenced in this study compared to the reference strain DSM 20075.
MIC (μg/ml) of antibiotics exhibited by the L. helveticus strains isolated in this study.
| UC1035 | ≤0.5 | 16 | 2 | 2 | 2 | 0.06 | 2 | |
| UC1266 | ≤0.5 | 16 | 1 | 2 | 2 | 0.03 | 2 | |
| UC1267 | ≤0.5 | ≤2 | ≤0.5 | 1 | 0.5 | ≤0.016 | 0.5 | |
| UC1275 | ≤0.5 | 4 | ≤0.5 | ≤0.5 | 1 | 0.06 | 0.06 | 2 |
| UC1285 | ≤0.5 | 4 | 1 | 1 | 1 | 0.03 | 1 | |
| UC3147 | ≤0.5 | ≤2 | 2 | 2 | 1 | 0.03 | 0.06 | 1 |
| DSM 20075 | ≤0.5 | ≤2 | ≤0.5 | ≤0.5 | 2 | 0.12 | 0.06 | 4 |
| EFSA cutoff values | 16 | 16 | 16 | – | 4 | 1 | 1 | 4 |